Insights From Large Randomized Statin Trials Molecular Cardiology Research Institute and Division of Cardiology, Department of Medicine, Tufts-New England Medical Center and Tufts University School of Medicine, Boston, Massachusetts. February 21, 2007. The authors of this study conclude, “The risk of cancer is significantly associated with lower achieved LDL-C levels”. And that “the cardiovascular benefits […]
MoreInsights From Large Randomized Statin Trials Molecular Cardiology Research Institute and Division of Cardiology, Department of Medicine, Tufts-New England Medical Center and Tufts University School of Medicine, Boston, Massachusetts. February 21, 2007. The authors of this study conclude, “The risk of cancer is significantly associated with lower achieved LDL-C levels”. And that “the cardiovascular benefits […]
MoreUse of Statin drugs for lowering cholesterol may lead to Parkinson’s disease A study reported by researchers at the University of North Carolina showed an excess number of cases of Parkinson’s disease diagnosed in those taking statin type medications to lower their cholesterol. These include Lipitor, Mevacor, Pravachol, Vitorin, and Crestor. What they showed was […]
MoreEver since their introduction into clinical medicine, the use of the cholesterol lowering drugs called statins, have been under a cloud of suspicion. That suspicion is the possibility that the interference in the body’s metabolism which results in a lowering of cholesterol levels may have a very negative side effect- the development of cancer. A […]
More